Table S1Activity of cherry-picked HTS hits against pPAFAH as assessed by gel-based competitive ABPP (AID 588474)

Compound lab nameSIDCID% Inhibition pPAFAH (5 μM Cpd)
A0349818553248174889%
A0449825105486955336%
A0514723122107576239%
A0617413867573436491%
A0749672084272909282%
A0849717433409529931%
A09496467771640687444%
A1049647446486879634%
A11248030393713423−3%
A1249716397150639321%
B0386552966678815%
B044964753272880324%
B0549735046435178030%
B067977938103725940%
B0724837627431821444%
B0849677790158214293%
B0924707853545945584%
B10248201891471280−3%
B1124823024160100396%
B124244777323932914%
C0349825219801664228%
C045646330918613616%
C0517414793533739023%
C0622405959243593830%
C07498273892481962410%
C0849717475247899748%
C094241429323640413%
C10796560451426550%
C1185198338355721219%
C124241939323685211%
D03426565189385723%
D044244235323885722%
D0514735286290116835%
D0614736542129196143%
D0724789783109290920%
D0842626146756775%
D091472778598301228%
D1014746123225135722%
D1149647657801621726%
D1285269573364267720%
E0314730879222776826%
E0449717482429945718%
E054246105324049024%
E06497196471603174013%
E07371281184782917%
E0885271190366614436%
E094244707323927210%
E10498252442481884930%
E115726344276131427%
E121474158918355175%
F0384587364823112%
F044973322221765145%
F05572578802516200864%
F0624790869504984810%
F071738599121043506%
F0849820822486885631%
F09425839197378018%
F10497174292478996918%
F11247826061618791524%
F1217385869118390610%
G0326671454292909415%
G0424818607148323140%
G0522409568327083724%
G0649717013757383318%
G074964575924747337100%
G0856323414931493144%
G095725732225161540−9%
G10497362772479374021%
G11572658941630700275%
G121473900022384858%
H03175043151200449045%
H04796748965193755%
H0584603264840465%
H0646500928324120810%
H0724791358327155840%
H08797276780707155%
H09564224522869315%
H10425144932451358%
H11498229871640693711%
H1256324777249831147%
I03572585882516259741%
I0485329465594684%
I05426531097730644%
I06496486671645747523%
I07563157731623198984%
I0849732024646201622%
I0917516379512256356%
I104972829010929263%
I1149728289109285621%
I12425658010929217%
J03224097111594532323%
J043714380299877438%
J05498159122454371855%
J06563215072498165528%
J0717432567134508245%
J08563171692497968916%
J097966421530821953%
J10563248832498315942%
J1126727296272631199%
K0385269967232710421%
K0417431795228250348%
K0514725991116004243%
K0685270454478369817%
K0749819107221357012%
K0849728592109273869%
K0914723216109287838%
K1049672846487677835%
K111750688129718628%
L032666479128877429%
L043716333208408554%
L0526669611297213447%
L06563245092498296624%
L0714739800133371227%
L0817508962115049839%
L09424128414801548%
L10498290011640665440%
L1149732864209687925%
M0314733155404882252%
M0424831877437411348%
M0549823145486903653%
M0649829271486913919%
M0724823472161954943%
M0849726570315211417%
M0926729061279573512%
M101741479553374019%
M1149665098486953418%
N031472801684792641%
N0414742766195162070%
N05498284421640674153%
N06563154121810858118%
N0714733456350569918%
N08572606481630623078%
N0914731640129869957%
N1049717138160342804%
N11563223662498206820%
O0324819918148662636%
O04797738574976622%
O05498288881758490073%
O0649829242496766437%
O07498208442481816510%
O08496456312474723629%
O0949733753109183424%
O10147391909551429%
O11496458841640684721%
P034264232223601379%
P0449717421410372041%
P0557263037459265053%
P0617413874222942546%
P07873341491606000918%
P0814723147100802830%
P094257433137878598%
P1014725052101520246%
P1114737509404882029%

From: Optimization and characterization of a carbamate inhibitor for plasma platelet-activating factor acetylhydrolase (pPAFAH)

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.